Have a personal or library account? Click to login
Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center Cover

Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center

Immunohematology
Volume 25 (2009): Issue 4 (December 2009)
By: D.M. Gribble,  D.J. Chaffin and  B.J. Bryant  
Paid access
|Mar 2020

Figures & Tables

Access Required

This content requires purchase or subscription access.

DOI: https://doi.org/10.21307/immunohematology-2019-251 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 170 - 173
Published on: Mar 20, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
hereditary hemochromatosis (HH),
FDA variance,
HH donor program
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2020 D.M. Gribble, D.J. Chaffin, B.J. Bryant, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 25 (2009): Issue 4 (December 2009)Next article